247 related articles for article (PubMed ID: 19419310)
1. Dose-dependent effects of Runx2 on bone development.
Zhang S; Xiao Z; Luo J; He N; Mahlios J; Quarles LD
J Bone Miner Res; 2009 Nov; 24(11):1889-904. PubMed ID: 19419310
[TBL] [Abstract][Full Text] [Related]
2. Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis.
Xiao ZS; Hjelmeland AB; Quarles LD
J Biol Chem; 2004 May; 279(19):20307-13. PubMed ID: 15007057
[TBL] [Abstract][Full Text] [Related]
3. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.
Xiao Z; Zhang S; Magenheimer BS; Luo J; Quarles LD
J Biol Chem; 2008 May; 283(18):12624-34. PubMed ID: 18321855
[TBL] [Abstract][Full Text] [Related]
4. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R
J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110
[TBL] [Abstract][Full Text] [Related]
5. MAML1 enhances the transcriptional activity of Runx2 and plays a role in bone development.
Watanabe T; Oyama T; Asada M; Harada D; Ito Y; Inagawa M; Suzuki Y; Sugano S; Katsube K; Karsenty G; Komori T; Kitagawa M; Asahara H
PLoS Genet; 2013; 9(1):e1003132. PubMed ID: 23326237
[TBL] [Abstract][Full Text] [Related]
6. SWI/SNF-independent nuclease hypersensitivity and an increased level of histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2.
Cruzat F; Henriquez B; Villagra A; Hepp M; Lian JB; van Wijnen AJ; Stein JL; Imbalzano AN; Stein GS; Montecino M
Biochemistry; 2009 Aug; 48(30):7287-95. PubMed ID: 19545172
[TBL] [Abstract][Full Text] [Related]
7. Advances in Runx2 regulation and its isoforms.
Li YL; Xiao ZS
Med Hypotheses; 2007; 68(1):169-75. PubMed ID: 16901655
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation.
Hinoi E; Fujimori S; Wang L; Hojo H; Uno K; Yoneda Y
J Biol Chem; 2006 Jun; 281(26):18015-24. PubMed ID: 16613847
[TBL] [Abstract][Full Text] [Related]
10. Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells.
Makita N; Suzuki M; Asami S; Takahata R; Kohzaki D; Kobayashi S; Hakamazuka T; Hozumi N
Gene; 2008 Apr; 413(1-2):8-17. PubMed ID: 18321663
[TBL] [Abstract][Full Text] [Related]
11. Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation.
Liu JC; Lengner CJ; Gaur T; Lou Y; Hussain S; Jones MD; Borodic B; Colby JL; Steinman HA; van Wijnen AJ; Stein JL; Jones SN; Stein GS; Lian JB
J Biol Chem; 2011 Aug; 286(34):30057-70. PubMed ID: 21676869
[TBL] [Abstract][Full Text] [Related]
12. Regulation of bone development and extracellular matrix protein genes by RUNX2.
Komori T
Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
[TBL] [Abstract][Full Text] [Related]
13. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.
Hassan MQ; Javed A; Morasso MI; Karlin J; Montecino M; van Wijnen AJ; Stein GS; Stein JL; Lian JB
Mol Cell Biol; 2004 Oct; 24(20):9248-61. PubMed ID: 15456894
[TBL] [Abstract][Full Text] [Related]
14. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.
Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM
J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4.
Tominaga H; Maeda S; Hayashi M; Takeda S; Akira S; Komiya S; Nakamura T; Akiyama H; Imamura T
Mol Biol Cell; 2008 Dec; 19(12):5373-86. PubMed ID: 18843047
[TBL] [Abstract][Full Text] [Related]
16. Runx2-I isoform contributes to fetal bone formation even in the absence of specific N-terminal amino acids.
Okura H; Sato S; Kishikawa S; Kaneto S; Nakashima T; Yoshida N; Takayanagi H; Kiyono H
PLoS One; 2014; 9(9):e108294. PubMed ID: 25244033
[TBL] [Abstract][Full Text] [Related]
17. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes.
Hassan MQ; Tare R; Lee SH; Mandeville M; Weiner B; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2007 May; 27(9):3337-52. PubMed ID: 17325044
[TBL] [Abstract][Full Text] [Related]
18. Spatio-temporal expression patterns of Runx2 isoforms in early skeletogenesis.
Choi KY; Lee SW; Park MH; Bae YC; Shin HI; Nam S; Kim YJ; Kim HJ; Ryoo HM
Exp Mol Med; 2002 Dec; 34(6):426-33. PubMed ID: 12526084
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic landscape during osteoblastogenesis defines a differentiation-dependent Runx2 promoter region.
Tai PW; Wu H; Gordon JA; Whitfield TW; Barutcu AR; van Wijnen AJ; Lian JB; Stein GS; Stein JL
Gene; 2014 Oct; 550(1):1-9. PubMed ID: 24881813
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of osteoblast gene expression profiles and Runx2 genomic occupancy of mouse and human osteoblasts in vitro.
Tarkkonen K; Hieta R; Kytölä V; Nykter M; Kiviranta R
Gene; 2017 Aug; 626():119-131. PubMed ID: 28502869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
